Logo
x

Search

Subscribe Now

respiratory syncytial virus

PharmaShots Interview: Jon Heinrichs of Sanofi Pasteur & Tonya Villafana of AstraZeneca Shares Insights on Nirsevimab in Healthy Infants Born at Term or Late Preterm

PharmaShots Interview: Jon Heinrichs of Sanofi Pasteur & Tonya Villafana of AstraZeneca Shares Insights on Nirsevimab in Healthy I...

  • April 19, 2022
Bavarian Nordic Plans to Initiate P-III Trial of Respiratory Syncytial Virus Candidate MVA-BN

Bavarian Nordic Plans to Initiate P-III Trial of Respiratory Syncytial Virus Candidate MVA-BN

  • December 6, 2021
Janssen Initiates P-III EVERGREEN Study of RSV Vaccine for the Treatment of Lower Respiratory Tract Disease Due to Respiratory Syncytial Virus

Janssen Initiates P-III EVERGREEN Study of RSV Vaccine for the Treatment of Lower Respiratory Tract Disease Due to Respiratory Syn...

  • September 30, 2021
Pfizer Initiates P-III RENOIR Trial of RSVpreF Vaccine for the Treatment of Respiratory Syncytial Virus

Pfizer Initiates P-III RENOIR Trial of RSVpreF Vaccine for the Treatment of Respiratory Syncytial Virus

  • September 3, 2021
GSK Initiates P-III study for RSV Candidate Vaccine Programme for Older Adults

GSK Initiates P-III study for RSV Candidate Vaccine Programme for Older Adults

  • February 17, 2021
Janssen's Investigational Prophylactic Vaccine Receives the US FDA's Breakthrough Therapy Designation to Prevent Respiratory Syncytial Virus

Janssen's Investigational Prophylactic Vaccine Receives the US FDA's Breakthrough Therapy Designation to Prevent Respiratory Syncy...

  • September 4, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.